Linnaeus Therapeutics
Business Services · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
30 Washington Ave Ste F, Haddonfield, Ne...Phone Number
(856) 433-1300Website
www.linnaeustx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Linnaeus Therapeutics
Linnaeus Therapeutics is a clinical-stage biopharmaceutical company that researches and develops novel small-molecule drugs targeting specific biological receptors to treat cancer and other diseases.Explore more
Linnaeus Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Linnaeus Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Linnaeus Therapeutics launches new products
Check if Linnaeus Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Linnaeus Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Linnaeus Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Linnaeus Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Linnaeus Therapeutics
Click to see if Linnaeus Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Linnaeus Therapeutics recently announced quarterly report
Recommended Actions
Find VP level buyers at Linnaeus Therapeutics
Find 3 more new buyers
Compare Similar Companies to Linnaeus Therapeutics
Compare insights from companies similar to Linnaeus Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Linnaeus Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Linnaeus Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Linnaeus Therapeutics.
Linnaeus Therapeutics financials insights
Gather financial insights about Linnaeus Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$4.3M
2018
Series A
$4.4M
2019
Series B
$12M
2021
Debt
$62K
2025
Debt
$1.3M
2026
Private Equity
$4.5M
Linnaeus Therapeutics Tech Stack
A closer look at the technologies used by Linnaeus Therapeutics
Most Recent Scoops
Funding
Funding
Funding
Funding
Funding
Linnaeus Therapeutics has received an SBA PPP loan in the amount of $62,500 from 1st Colonial Community Bank resulting in the retention of 3 jobs.
Funding
Funding
Linnaeus Therapeutics News & Media
Linnaeus Therapeutics Awarded Up to $22 Million from ARPA-H to Advance LNS8801 for Healthspan Preservation
ARPA-H PROSPR program to support accelerated development of LNS8801 to promote healthy aging ARPA-H PROSPR program to support accelerated development of LNS8801 to promote healthy agingLinnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million
$2,000,000 Direct-to-Phase 2 Award Funds Study of LNS8801 in the Treatment of Melanoma HADDONFIELD, N.J., March 26, 2025 /PRNewswire/ -- Linnaeus Therapeutics, Inc. ("Linnaeus"), a privately held biopharmaceutical company focused on the development and commercialization of novel small...Linnaeus Therapeutics Announces Publication of Seminal Paper on LNS8801 in Cancer Research Communications
HADDONFIELD, N.J., March 20, 2025 /PRNewswire/ -- Linnaeus Therapeutics, Inc. ("Linnaeus"), a privately held biopharmaceutical company focused on the development and commercialization of novel, small molecule oncology therapeutics, today announced that seminal data describing Linnaeus's...Linnaeus Therapeutics Announces Issuance of Composition of Matter Patent for LNS8801 by the European Patent Office
European Patent 3,823,617 Issued on March 6, 2024 HADDONFIELD N.J., April 2, 2024 /PRNewswire/ -- Linnaeus Therapeutics, Inc. (Linnaeus), a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Linnaeus Therapeutics
Sign Up For FreeTo access detailed company insights
Linnaeus Therapeutics is a clinical-stage biopharmaceutical company that researches and develops novel small-molecule drugs targeting specific biological receptors to treat cancer and other diseases.... Read More
